Hit enter to search or ESC to close
Menu
Home
Biocellvia
Therapeutic Areas
Preclinical
Clinical
Tailor-made assay
Publications
Contact
Filter
All
COPD
IPF
NASH / NAFLD
Paris Nash 2021
Poster
The telomerase activator TA‐65 protects from cigarette smoke‐induced small airway remodeling in mice through extra‐telomeric effects
Cigarette smoke-induced gasdermin D activation in bronchoalveolar macrophages and bronchial epithelial cells dependently on NLRP3
DISTRIBUTION OF LIPID VESICLE SIZE AS POTENTIAL MARKER OF NAS SEVERITY: ASSESSMENT WITH MORPHOQUANT-NASH AND MRI
Time-efficient and Reliable Automated Liver Fibrosis Quantification in Preclinical Fibrosis Models using WSI
Automated Digital Quantification of Pulmonary Fibrosis in Human Histopathology Specimens
Elevation of IL-6 and IL-33 Levels in Serum Associated with Lung Fibrosis and Skeletal Muscle Wasting in a Bleomycin-Induced Lung Injury Mouse Model
CSF1R inhibition prevents radiation pulmonary fibrosis by depletion of interstitial macrophages
Radiation-induced lung fibrosis is associated with M2 interstitial and hybrid alveolar macrophages
Engineering DNA vaccines against infectious diseases
Development of pulmonary fibrosis after heart failure induced by elevated left atrial pressure
A fully automated image analysis method to quantify lung fibrosis in the bleomycin- induced rat model
Utilization of a Deep Learning Algorithm for Microscope-Based Fatty Vacuole Quantification in a Fatty Liver Model in Mice
Inhibition of mast cells: a novel mechanism by which nintedanib may elicit anti-fibrotic effects
Lanatoside C protects mice against bleomycin-induced pulmonary fibrosis through suppression of fibroblast proliferation and differentiation
Consumption of a high energy density diet triggers microbiota dysbiosis, hepatic lipidosis, and microglia activation in the nucleus of the solitary tract in rats
Existing and emerging treatments for idiopathic pulmonary fibrosis
Oral Administration of Chitosan Attenuates Bleomycin-induced Pulmonary Fibrosis in Rats
Polyporus Polysaccharide Ameliorates Bleomycin-Induced Pulmonary Fibrosis by Suppressing Myofibroblast Differentiation via TGF-b/Smad2/3 Pathway
Deep neural network based histological scoring of lung fibrosis and inflammation in the mouse model system
Longitudinal study of Pex1-G844D NMRI mouse model: A robust pre-clinical T model for mild Zellweger spectrum disorder
Monitoring the Health Status of Mice with Bleomycin-induced Lung Injury by Using Body Condition Scoring
Mitofusins regulate lipid metabolism to mediate the development of lung fibrosis
Bleomycin Revisited: A Direct Comparison of the Intratracheal Micro-Spraying and the Oropharyngeal Aspiration Routes of Bleomycin Administration in Mice
Early microcystin-LR exposure-linked inflammasome activation in mice causes development of fatty liver disease and insulin resistance
Follow-up of NAFLD/NASH progression using an automated histological image analysis
Fully Automated Histology Analysis Correlates with Ashcroft Scoring, MicroCT Analysis and Lung Function Measurement in a Mouse Model of Bleomycin-induced Lung Fibrosis
Distal lung epithelial progenitor cell function declines with age
Diet Reversal and Immune Modulation Show Key Role for Liver and Adipose Tissue T Cells in Murine Nonalcoholic Steatohepatitis
Automated computerized image analysis for the user-independent evaluation of disease severity in preclinical models of NAFLD/NASH
Exogenous PP2A inhibitor exacerbates the progression of nonalcoholic fatty liver disease via NOX2-dependent activation of miR21
Functional and morphological differences of the lung upon acute and chronic ozone exposure in mice.
Quantification of Pulmonary Fibrosis in a Bleomycin Mouse Model Using Automated Histological Image Analysis.
Home
Biocellvia
Therapeutic Areas
Preclinical
Clinical
Tailor-made assay
Publications
Contact